Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Mian%2C+Afsar+Ali%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Mian%2C+Afsar+Ali%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Mian%2C+Afsar+Ali%22&type=Person&sort=year
PubPharm (19)
1
Prioritization of The Zinc finger domain within
BCL11A by the
Amelioration capability of hemoglobinopathies using CRISPR-Cas9 technology
enthalten in:
bioRxiv.org
| 2023
von
Mumtaz, K.
|
Hussain, I.
|
Iftikhar, F.
| +7
Wird geladen...
2
Lyophilization Based Isolation of Exosomes
enthalten in:
International journal of molecular sciences
| 2023
von
Qazi, R.
|
Sajid, Z.
|
Zhao, C.
| +5
Wird geladen...
3
Subtractive Interaction Proteomics Reveal a Network of Signaling Pathways Activated by an Oncogenic Transcription Factor in Acute Myeloid Leukemia
enthalten in:
bioRxiv.org
| 2022
von
Guillen, N.
|
Wieske, M.
|
Otto, A.
| +12
Wird geladen...
4
Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway
enthalten in:
Neoplasia (New York, N.Y.)
| 2021
von
Mian, A.
|
Zafar, U.
|
Ahmed, S.
| +2
Wird geladen...
5
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K
enthalten in:
Annals of hematology
| 2021
von
Mian, A.
|
Haberbosch, I.
|
Khamaisie, H.
| +10
Wird geladen...
6
AXL receptor tyrosine kinase : a possible therapeutic target in acute promyelocytic leukemia
enthalten in:
BMC cancer
| 2021
von
Fatima, M.
|
Kakar, S.
|
Adnan, F.
| +3
Wird geladen...
7
AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia
enthalten in:
BMC cancer
| 2021
von
Fatima, M.
|
Kakar, S.
|
Adnan, F.
| +3
Wird geladen...
8
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-$ ABL1^{T315I} $ and BCR-$ ABL1^{T315I-E255K} $
enthalten in:
Annals of hematology
| 2021
von
Mian, A.
|
Haberbosch, I.
|
Khamaisie, H.
| +10
Wird geladen...
9
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-$ ABL1^{T315I} $ and BCR-$ ABL1^{T315I-E255K} $
enthalten in:
Annals of hematology
| 2021
von
Mian, A.
|
Haberbosch, I.
|
Khamaisie, H.
| +10
Wird geladen...
10
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-$ ABL1^{T315I} $ and BCR-$ ABL1^{T315I-E255K} $
enthalten in:
Annals of hematology
| 2021
von
Mian, A.
|
Haberbosch, I.
|
Khamaisie, H.
| +10
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
18
Aufsätze
16
E-Ressourcen
15
E-Artikel
3
Gedruckte Aufsätze
1
Bücher
1
E-Books
1
Hochschulschriften
Alle anzeigen ...
weniger ...
Zeitschriftentitel
5
BMC cancer
4
Annals of hematology
2
Genes & cancer
2
bioRxiv.org
1
Blood
1
International journal of molecular sciences
1
Journal of infection in developing countries
1
Neoplasia (New York, N.Y.)
1
PLoS genetics
Alle anzeigen ...
weniger ...
Thema
9
Journal Article
6
Allosteric inhibition
5
BCR-ABL1
4
Antineoplastic Agents
4
Compound mutations
4
Crizotinib
4
Philadelphia chromosome–positive leukemia
4
TKI resistance
3
BCR/ABL
3
EC 2.7.10.2
3
Fusion Proteins, bcr-abl
3
Research Support, Non-U.S. Gov't
2
570
2
AXL
2
Abl kinase inhibitors
2
Acute promyelocytic leukemia
2
Biology
2
Molecular therapy
2
PML/RARα
2
Philadelphia chromosome
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
8
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
19
Englisch
Haven't found what you're looking for?
Wird geladen...